Literature DB >> 30186002

Identifying Drug Interactions between Enzalutamide and Complementary Alternative Medications in a Patient with Metastatic Prostate Cancer: A Case Report.

Thomas Brownlee1, Colleen Olson2, Michelle Deschamps3.   

Abstract

Entities:  

Year:  2018        PMID： 30186002      PMCID： PMC6118822     

Source DB:  PubMed          Journal:  Can J Hosp Pharm        ISSN： 0008-4123


× No keyword cloud information.
  13 in total

Review 1.  Complementary and alternative medicine during cancer treatment: beyond innocence.

Authors:  Metin Tascilar; Floris A de Jong; Jaap Verweij; Ron H J Mathijssen
Journal:  Oncologist       Date:  2006 Jul-Aug

2.  Proposal for a new tool to evaluate drug interaction cases.

Authors:  John R Horn; Philip D Hansten; Lingtak-Neander Chan
Journal:  Ann Pharmacother       Date:  2007-03-27       Impact factor: 3.154

3.  Perception of cancer patients of their disease, self-efficacy and locus of control and usage of complementary and alternative medicine.

Authors:  Marie-Desirée Ebel; Ivonne Rudolph; Christian Keinki; Andrea Hoppe; Ralph Muecke; Oliver Micke; Karsten Muenstedt; Jutta Huebner
Journal:  J Cancer Res Clin Oncol       Date:  2015-02-22       Impact factor: 4.553

4.  Herb-drug interactions in oncology.

Authors:  A K L Goey; J H Beijnen; J H M Schellens
Journal:  Clin Pharmacol Ther       Date:  2014-04       Impact factor: 6.875

Review 5.  The role of drug-drug interactions in prostate cancer treatment: Focus on abiraterone acetate/prednisone and enzalutamide.

Authors:  Marzia Del Re; Stefano Fogli; Lisa Derosa; Francesco Massari; Paul De Souza; Stefania Crucitta; Sergio Bracarda; Daniele Santini; Romano Danesi
Journal:  Cancer Treat Rev       Date:  2017-03-09       Impact factor: 12.111

6.  Enzalutamide Versus Bicalutamide in Castration-Resistant Prostate Cancer: The STRIVE Trial.

Authors:  David F Penson; Andrew J Armstrong; Raoul Concepcion; Neeraj Agarwal; Carl Olsson; Lawrence Karsh; Curtis Dunshee; Fong Wang; Kenneth Wu; Andrew Krivoshik; De Phung; Celestia S Higano
Journal:  J Clin Oncol       Date:  2016-01-25       Impact factor: 44.544

Review 7.  Cancer patients taking herbal medicines: A review of clinical purposes, associated factors, and perceptions of benefit or harm.

Authors:  Benjawan Poonthananiwatkul; Rachel L Howard; Elizabeth M Williamson; Rosemary H M Lim
Journal:  J Ethnopharmacol       Date:  2015-09-03       Impact factor: 4.360

Review 8.  Role of testosterone in managing advanced prostate cancer.

Authors:  Kyle O Rove; Frans M Debruyne; Bob Djavan; Leonard G Gomella; Hari K Koul; M Scott Lucia; Daniel P Petrylak; Neal D Shore; Nelson N Stone; E David Crawford
Journal:  Urology       Date:  2012-07-13       Impact factor: 2.649

9.  Pharmacokinetic Drug Interaction Studies with Enzalutamide.

Authors:  Jacqueline A Gibbons; Michiel de Vries; Walter Krauwinkel; Yoshiaki Ohtsu; Jan Noukens; Jan-Stefan van der Walt; Roelof Mol; Joyce Mordenti; Taoufik Ouatas
Journal:  Clin Pharmacokinet       Date:  2015-10       Impact factor: 6.447

10.  Role of free testosterone levels in patients with metastatic castration-resistant prostate cancer receiving second-line therapy.

Authors:  Christoph A von Klot; Markus A Kuczyk; Alena Boeker; Christoph Reuter; Florian Imkamp; Thomas R W Herrmann; Hossein Tezval; Mario W Kramer; Sven Perner; Axel S Merseburger
Journal:  Oncol Lett       Date:  2016-11-17       Impact factor: 2.967
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.